Home / Life Sciences / Key developments and materials / Weekly highlights

Legal News

Life Sciences weekly highlights—1 August 2019

Copyright © 2025 LexisNexis

Published on: 01 August 2019

Published by a LexisNexis Life Sciences expert

Table of contents

Brexit
Can Parliament prevent a no deal Brexit?
Human Medicines and Medical Devices (Amendment etc) (EU Exit) Regulations 2019
Intellectual property
Trade mark use in clinical trials, no bar to non-use revocation (Viridis Pharmaceuticals Ltd)
Business transactions
Governing law—time to distinguish between English and Welsh law?
Daily and weekly news alerts
New and updated content
Updated Practice Notes

More sections of this document available when you sign-in to Lexis+ or register for a free trial.

Article summary

This week's edition of Life Sciences weekly highlights includes analysis of the judgment in Viridis Pharmaceuticals on trade mark use in clinical trials, the draft of the Human Medicines and Medical Devices (Amendment) etc (EU Exit) Regulations 2019, as well as a discussion of whether Parliament can prevent a no deal Brexit.

Popular documents

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of